Knock Out Mouse Model Market Size, Share, Trends, Growth Outlook

Knock Out Mouse Model Market is estimated to increase at a Compounded Annual Growth Rate of 5.8% CAGR over the forecast period from 2024 to 2030

The Knock Out Mouse Model Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Type (Constitutive, Conditional, Protein Function), By Application (Oncology, Neurology, Cardiovascular, Others), By End-User (Clinical Research Organizations, Pharma & Biotechnology Companies, Others).

An Introduction to Knock Out Mouse Model Market in 2024

In 2024, the market for knock-out mouse models remains indispensable in biomedical research, offering valuable tools for investigating gene function, disease mechanisms, and therapeutic targets in vivo. Knock-out mice are genetically engineered animals in which a specific gene of interest has been rendered non-functional, allowing researchers to study the effects of gene loss on phenotype and physiology. These models have revolutionized our understanding of gene function and the pathogenesis of human diseases, including cancer, neurodegenerative disorders, metabolic diseases, and autoimmune conditions. With advancements in genome editing technologies such as CRISPR-Cas9, the development of knock-out mouse models has become more efficient, precise, and versatile, enabling the generation of complex genetic modifications and disease-relevant phenotypes. Knock-out mouse models continue to play a central role in preclinical drug discovery and development, target validation, and translational research, facilitating the development of novel therapeutics and personalized medicine approaches. As the demand for genetically accurate and clinically relevant animal models increases, the market for knock-out mouse models is poised for sustained growth and innovation, driving advancements in biomedical science and healthcare.

Market Trend: Increasing Demand for Precision Medicine Research

A prominent trend in the knockout mouse model market is the increasing demand for precision medicine research. Knock-out mouse models, which involve the targeted deletion or modification of specific genes, play a crucial role in understanding the genetic basis of human diseases and developing targeted therapies tailored to individual patient characteristics. As precision medicine approaches gain traction in healthcare, there is growing interest in using knock-out mouse models to elucidate disease mechanisms, identify therapeutic targets, and evaluate the efficacy of novel treatments. Researchers and pharmaceutical companies are leveraging knock-out mouse models to accelerate drug discovery and development efforts, leading to personalized and more effective therapies for a wide range of diseases, including cancer, neurological disorders, and genetic conditions.

Market Driver: Advancements in Gene Editing Technologies

A key driver for the knock out mouse model market is the advancements in gene editing technologies. Recent innovations in genome editing tools, such as CRISPR-Cas9, TALENs, and zinc finger nucleases, have revolutionized the field of mouse genetics by enabling precise and efficient manipulation of the mouse genome. These gene editing techniques allow researchers to create knock out mouse models with greater speed, accuracy, and specificity, facilitating the generation of animal models that closely mimic human diseases. The widespread adoption of gene editing technologies in academic research institutions, pharmaceutical companies, and contract research organizations (CROs) drives the demand for knock-out mouse models as indispensable tools for studying gene function, disease pathogenesis, and therapeutic interventions.

Market Opportunity: Expansion into Rare Disease Research and Drug Development

An emerging opportunity in the knock out mouse model market lies in the expansion into rare disease research and drug development. Rare diseases, which often have a genetic basis and limited treatment options, present significant unmet medical needs and therapeutic challenges. Knock-out mouse models offer valuable platforms for studying the molecular mechanisms underlying rare diseases, identifying potential drug targets, and evaluating the efficacy of investigational therapies. By collaborating with patient advocacy groups, academic researchers, and pharmaceutical companies, providers of knock-out mouse models can support efforts to advance rare disease research and drug development, ultimately improving outcomes for patients affected by these conditions. Additionally, the development of novel knock-out mouse models tailored to specific rare diseases and genetic mutations presents opportunities for innovation and differentiation in the knock-out mouse model market, addressing critical gaps in preclinical research and translational medicine.

Knock Out Mouse Model Market Share Analysis: Oncology Application

In the Knock Out Mouse Model Market, the segment experiencing the fastest growth is the Oncology Application. Knock out mouse models play a crucial role in oncology research by enabling scientists to study the genetic mechanisms underlying cancer development, progression, and response to treatment. These models involve the targeted deletion or modification of specific genes associated with oncogenesis, allowing researchers to mimic human cancer conditions in mice and investigate novel therapeutic strategies. The oncology application of knock-out mouse models has gained traction due to the increasing prevalence of cancer worldwide and the urgent need for innovative cancer therapies. Moreover, advancements in gene editing technologies, such as CRISPR/Cas9, have facilitated the development of more sophisticated knock-out mouse models with enhanced precision and efficiency, further driving their adoption in oncology research. With ongoing efforts to elucidate the molecular pathways involved in cancer pathogenesis and identify druggable targets, the demand for knock out mouse models in oncology applications is expected to continue growing rapidly. Consequently, the Oncology Application segment is poised for significant expansion in the Knock Out Mouse Model Market.

Knock Out Mouse Model Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossCharles River Laboratories International Inc, Cyagen Biosciences Inc, Envigo Corp, genOway S.A., Ingenious Targeting Laboratory, Ozgene Pty Ltd, Taconic Biosciences Inc, The Jackson Laboratory, Trans Genic Inc, Ximbio Ltd

Knock Out Mouse Model Market Segmentation

By Type
Constitutive
Conditional
Protein Function
By Application
Oncology
Neurology
Cardiovascular
Others
By End-User
Clinical Research Organizations
Pharma & Biotechnology Companies
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Knock Out Mouse Model Market Companies

Charles River Laboratories International Inc
Cyagen Biosciences Inc
Envigo Corp
genOway S.A.
Ingenious Targeting Laboratory
Ozgene Pty Ltd
Taconic Biosciences Inc
The Jackson Laboratory
Trans Genic Inc
Ximbio Ltd

Reasons to Buy the Knock Out Mouse Model Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Knock Out Mouse Model Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Knock Out Mouse Model Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Knock Out Mouse Model Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Knock Out Mouse Model Market Size Outlook, $ Million, 2021 to 2030
3.2 Knock Out Mouse Model Market Outlook by Type, $ Million, 2021 to 2030
3.3 Knock Out Mouse Model Market Outlook by Product, $ Million, 2021 to 2030
3.4 Knock Out Mouse Model Market Outlook by Application, $ Million, 2021 to 2030
3.5 Knock Out Mouse Model Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Knock Out Mouse Model Industry
4.2 Key Market Trends in Knock Out Mouse Model Industry
4.3 Potential Opportunities in Knock Out Mouse Model Industry
4.4 Key Challenges in Knock Out Mouse Model Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Knock Out Mouse Model Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Knock Out Mouse Model Market Outlook by Segments
7.1 Knock Out Mouse Model Market Outlook by Segments, $ Million, 2021- 2030
By Type
Constitutive
Conditional
Protein Function
By Application
Oncology
Neurology
Cardiovascular
Others
By End-User
Clinical Research Organizations
Pharma & Biotechnology Companies
Others

8 North America Knock Out Mouse Model Market Analysis and Outlook To 2030
8.1 Introduction to North America Knock Out Mouse Model Markets in 2024
8.2 North America Knock Out Mouse Model Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Knock Out Mouse Model Market size Outlook by Segments, 2021-2030
By Type
Constitutive
Conditional
Protein Function
By Application
Oncology
Neurology
Cardiovascular
Others
By End-User
Clinical Research Organizations
Pharma & Biotechnology Companies
Others

9 Europe Knock Out Mouse Model Market Analysis and Outlook To 2030
9.1 Introduction to Europe Knock Out Mouse Model Markets in 2024
9.2 Europe Knock Out Mouse Model Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Knock Out Mouse Model Market Size Outlook by Segments, 2021-2030
By Type
Constitutive
Conditional
Protein Function
By Application
Oncology
Neurology
Cardiovascular
Others
By End-User
Clinical Research Organizations
Pharma & Biotechnology Companies
Others

10 Asia Pacific Knock Out Mouse Model Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Knock Out Mouse Model Markets in 2024
10.2 Asia Pacific Knock Out Mouse Model Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Knock Out Mouse Model Market size Outlook by Segments, 2021-2030
By Type
Constitutive
Conditional
Protein Function
By Application
Oncology
Neurology
Cardiovascular
Others
By End-User
Clinical Research Organizations
Pharma & Biotechnology Companies
Others

11 South America Knock Out Mouse Model Market Analysis and Outlook To 2030
11.1 Introduction to South America Knock Out Mouse Model Markets in 2024
11.2 South America Knock Out Mouse Model Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Knock Out Mouse Model Market size Outlook by Segments, 2021-2030
By Type
Constitutive
Conditional
Protein Function
By Application
Oncology
Neurology
Cardiovascular
Others
By End-User
Clinical Research Organizations
Pharma & Biotechnology Companies
Others
12 Middle East and Africa Knock Out Mouse Model Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Knock Out Mouse Model Markets in 2024
12.2 Middle East and Africa Knock Out Mouse Model Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Knock Out Mouse Model Market size Outlook by Segments, 2021-2030
By Type
Constitutive
Conditional
Protein Function
By Application
Oncology
Neurology
Cardiovascular
Others
By End-User
Clinical Research Organizations
Pharma & Biotechnology Companies
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Charles River Laboratories International Inc
Cyagen Biosciences Inc
Envigo Corp
genOway S.A.
Ingenious Targeting Laboratory
Ozgene Pty Ltd
Taconic Biosciences Inc
The Jackson Laboratory
Trans Genic Inc
Ximbio Ltd

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Constitutive
Conditional
Protein Function
By Application
Oncology
Neurology
Cardiovascular
Others
By End-User
Clinical Research Organizations
Pharma & Biotechnology Companies
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)